Treatment of pulmonary arterial hypertension (PAH) with oral endothelin-receptor antagonist bosentan in systemic sclerosis: BREATHE-1 trial and clinical experience

被引：0
|
作者：
Ahmadi-Simab, K
Lamprecht, P
Hellmisch, B
Gross, WL
机构：
[1] Univ Klinikum Schleswig Holstein, Poliklin Rheumatol, D-23538 Lubeck, Germany
[2] Rheumaklin Bad Bramstedt, D-23538 Lubeck, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2004年 / 63卷 / 06期
关键词：
D O I：
10.1007/s00393-004-0594-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：495 / 497
页数：3
相关论文
共 50 条
  • [1] Therapie der pulmonalen arteriellen Hypertonie (PAH) mit dem oralen Endothelin-Rezeptor Antagonisten Bosentan bei systemischer Sklerose: Die BREATHE-1-Studie und klinische ErfahrungenTreatment of pulmonary arterial hypertension (PAH) with oral endothelin-receptor antagonist bosentan in systemic sclerosis: BREATHE-1 trial and clinical experience
    K. Ahmadi-Simab
    P. Lamprecht
    B. Hellmisch
    W. L. Gross
    Zeitschrift für Rheumatologie, 2004, 63 (6) : 495 - 497
  • [2] Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension
    Halank, M
    Miehlke, S
    Hoeffken, G
    Schmeisser, A
    Schulze, M
    Strasser, RH
    TRANSPLANTATION, 2004, 77 (11) : 1775 - 1776
  • [3] The endothelin-receptor antagonist bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects
    Sitbon, O
    Beghetti, M
    Petit, J
    Iserin, L
    Humbert, M
    Gressin, V
    Simonneau, G
    EUROPEAN HEART JOURNAL, 2004, 25 : 22 - 22
  • [4] Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan
    Humbert, M
    Cabane, J
    RHEUMATOLOGY, 2003, 42 (01) : 191 - 193
  • [5] Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension
    Galiè, N
    Hinderliter, AL
    Torbicki, A
    Fourme, T
    Simonneau, G
    Pulido, T
    Espinola-Zavaleta, N
    Rocchi, G
    Manes, A
    Frantz, R
    Kurzyna, M
    Nagueh, SF
    Barst, R
    Channick, R
    Dujardin, K
    Kronenberg, A
    Leconte, I
    Rainisio, M
    Rubin, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (08) : 1380 - 1386
  • [6] Sitaxsentan - A new endothelin-receptor antagonist for the treatment of pulmonary arterial hypertension
    Reinhart, Kurt
    White, C. Michael
    FORMULARY, 2007, 42 (05) : 295 - +
  • [7] Pharmacokinetics and safety of bosentan, an oral dual endothelin receptor antagonist in children with pulmonary arterial hypertension: BREATHE-3
    Barst, R
    Ivy, D
    Widlitz, AC
    Moore, K
    Doran, A
    Nguyen, N
    Gaitonde, MD
    EUROPEAN HEART JOURNAL, 2002, 23 : 489 - 489
  • [8] Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats
    Chen, SJ
    Chen, YF
    Meng, QC
    Durand, J
    Dicarlo, VS
    Oparil, S
    JOURNAL OF APPLIED PHYSIOLOGY, 1995, 79 (06) : 2122 - 2131
  • [9] Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis
    John Varga
    Current Rheumatology Reports, 2003, 5 (2) : 145 - 146
  • [10] Digital ulcers in systemic sclerosis - Prevention by treatment with bosentan, an oral endothelin receptor antagonist
    Korn, JH
    Mayes, M
    Cerinic, MM
    Rainisio, M
    Pope, J
    Hachulla, E
    Rich, E
    Carpentier, P
    Molitor, J
    Seibold, JR
    Hsu, V
    Guillevin, L
    Chatterjee, S
    Peter, HH
    Coppock, J
    Herrick, A
    Merkel, PA
    Simms, R
    Denton, CP
    Furst, D
    Nguyen, N
    Gaitonde, M
    Black, C
    ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 3985 - 3993
12345